National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

 1037

Statutory Rules

1975 No. 209

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1975.*

The Pharmaceutical Benefits Advisory Committee having recommended to the Minister of State for Health under sub-section 101 (4) of the National Health Act 1953-1975 that the drug or medicinal preparation specified in Schedule 3 to the following Regulations be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act, I, THE GOVERNOR-GENERAL of Australia, acting with the advice of the Executive Council, make the following Regulations under that Act.

Dated this nineteenth day of November, 1975.

JOHN R. KERR

Governor-General.

By His Excellency's Command,

D. L. CHIPP

Minister of State for Health.

________

 

Amendments of the National Health (Pharmaceutical Benefits) Regulation 

Commencement.

1. These Regulations shall come into operation on 1 December 1975.

First Schedule.

2. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 1.

Second Schedule.

3. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 2.

Third Schedule.

4. The Third Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 3.

Fifth Schedule.

5. The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 4.

_________________________________________________________________________________

* Notified in the Australian Government Gazette on 21 November 1975.

  Statutory Rules 1960, No. 17, as amended to date. For previous amendments to the National Health (Pharmaceutical Benefits) Regulations see footnote   to Statutory Rules 1975, No. 50 and see also Statutory Rules 1975, Nos. 30 and 148.

 SCHEDULE 1  Regulation 2

Amendments of the First Schedule to the National Health (Pharmaceutical Benefits) Regulations

1. After item 50 insert the following item:—

“ 50a Calcium Gluconate Injection ”.

2. After item 52 insert the following item:—

“ 52a Carbachol Injection ”.

3. After item 104 insert the following item:—

“ 104a Cortisone Injection ”.

4. After item 117 insert the following item:—

“ 117a Demeclocycline Hydrochloride ”.

5. After item 329 insert the following item:—

“ 329a Methylergometrine Injection ”.

6. After item 374 insert the following item:—

“ 374a Papaverine Hydrochloride ”.

7. After item 375 insert the following item:—

“ 375a Paramethadione Capsules ”.

8. Omit item 393.

9. After item 423 insert the following items:—

“ 423a Practolol Injection

423b Practolol Tablets ”.

10. Omit item 541.

11. After item 546 insert the following item:—

“ 546a Troxidone ”.

________

 SCHEDULE 2

Regulation 3

Amendments of the Second Schedule to the National Health (Pharmaceutical Benefits) Regulations

1. Omit item 57.

2. Omit item 152, substitute the following item:—

“ 152	Nystatin...........................................	Gramicidin with Neomycin Sulphate, Triamcinolone Acetonide and Nystatin
Oxytetracycline Dihydrate with Nystatin
Tetracycline, B.P.C., with a buffering agent and Nystatin
Tetracycline Hydrochloride with Nystatin ”.

3. Omit item 221, substitute the following item:—

“ 221 Tetracycline Hydrochloride .. Tetracycline Hydrochloride with Nystatin ”.

__________

 SCHEDULE 3

Regulation 4

Amendments of the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations

1. After item 53 insert the following item:—

“ 53a Bufexamac ”.

2. Omit item 124.

3. Omit item 233.

 SCHEDULE 4  Regulation 5

Amendments of the Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations

1. Omit item 6, substitute the following item:—

“ 6 Amantadine Hydrochloride................ The treatment of Parkinson's disease caused otherwise than by treatment with a drug ”.

2. Omit items 9 and 10.

3. Omit item 110.

4. Omit item 112.

5. After item 126 insert the following item:—

“ 126a	Phenelzine Tablets, B.P.....................	Depressive illness resistant to treatment with tricyclic antidepressants or electro-convulsive therapy;
Obsessive compulsive neurosis ”.

6. Omit item 131.

7. Omit item 134.

8. After item 165 insert the following item:—

“ 165a	Tranylcypromine Tablets, B.P.	Depressive illness resistant to treatment with tricyclic antidepressants or electro-convulsive therapy;
Obsessive compulsive neurosis ”.